Vandana Singh
·
March 27, 2025
Benzinga
Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.
read more
June 15, 2025
April 15, 2025
Barchart
May 2, 2025
May 16, 2025
Bloomberg